Woodcock Faces Maze Of Rules To Become Commissioner Nominee
Executive Summary
If Biden administration wants to nominate the acting commissioner, Vacancies Reform Act would dictate the timing. Woodcock can still get the nod and remain head of the agency during the confirmation process, just as Andrew von Eschenbach retained his acting title following his nomination in 2006.
You may also be interested in...
Campaign Against Woodcock’s US FDA Commissioner Bid Has Begun
Opioid issues delayed Robert Califf’s confirmation as FDA commissioner. Could they prevent the nomination of Janet Woodcock?
Woodcock To Be Acting US FDA Commissioner, Leaving Agency in Stable, Capable Hands
Agency has been prepping Woodcock for the temporary task but what will happen to her role on Operation Warp Speed remains unclear. The move should give Biden team cushion to confirm a permanent leader of whom a top contender is former senior FDA staffer Joshua Sharfstein, a proponent of drug reforms that may irk manufacturers.
Von Eschenbach Nomination Clears Senate Handily
Senate agrees by large margin to break Sen. Grassley's "hold" against vote.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: